MedPath

The decreasing effect of rose hip-derived tiliroside on the abdominal visceral fat - A systematic review

Not Applicable
Conditions
Healthy adult volunteers
Registration Number
JPRN-UMIN000030442
Lead Sponsor
Morishita Jintan Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1
Inclusion Criteria

Not provided

Exclusion Criteria

The literature which does not meet the key inclusion criteria will be excluded.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Abdominal visceral fat area
Secondary Outcome Measures
NameTimeMethod
Abdominal Subcutaneous fat area Abdominal Total fat area Body Mass Index (BMI)
© Copyright 2025. All Rights Reserved by MedPath